Endolymphatic Hydrops: The Finding Behind Ménière's, and Why You Can Have One Without the Other

This page exists because two words get used as if they meant the same thing, and they do not. If you have been told you have "hydrops" and cannot work out whether that means you have Ménière's disease, the answer is that it is a different kind of statement.

Two different kinds of thing

Endolymphatic hydrops is a finding. The inner ear contains a fluid-filled space — the endolymphatic system — and hydrops is that space being distended. It is a description of a physical state.

Ménière's disease is a syndrome. A 2016 review in the Journal of Neurology characterises it as episodic attacks of vertigo, fluctuating hearing loss, tinnitus and aural pressure, with progressive loss of hearing and balance function over time. It gives a prevalence of 200 to 500 per 100,000, which places it as uncommon rather than rare. Ménière's disease and tinnitus covers that syndrome in its own right.

The relationship between them has been understood in outline for a long time. The review notes that Prosper Menière identified the inner ear as the site of the problem over 150 years ago, and that endolymphatic hydrops was discovered as its pathologic correlate over 75 years ago.

The seventy-five-year problem

Here is what makes this subject unusual, and it explains most of the confusion around it.

For nearly all of those 75 years, hydrops could only be confirmed after death. The review is direct about it: the pathologic finding could be ascertained only in post-mortem histologic studies.

So an entire clinical field had to work with a condition whose defining physical feature was, in the living, invisible. The consequence the review describes follows inevitably: because of that diagnostic dilemma and the variable way the symptoms show up, classification systems based on clinical findings were repeatedly modified and were not used uniformly across the research literature.

That is worth holding onto when reading anything about Ménière's. Studies from different decades and different countries were not always describing the same population, because the criteria kept moving and the underlying finding could not be checked.

The review adds a second gap, and it is one this site keeps meeting elsewhere: the higher-level measures of what the condition does to a life — vitality and social participation — had been neglected. Attack frequency was counted. Whether someone still went out was not.

What MRI changed

The development the 2016 review is built around: high-resolution MR imaging of the inner ear now makes it possible to visualise endolymphatic hydrops in living patients with suspected Ménière's disease.

That is a genuine before-and-after in this field. It also complicated the tidy version rather than confirming it, which is the more interesting result.

Reviewing the temporal bone histology together with the emerging imaging evidence, the authors conclude that hydrops is responsible not only for the full clinical triad — simultaneous attacks of hearing and balance dysfunction — but also for other presentations, which the literature describes as "vestibular" and "cochlear" Ménière's disease. On that basis they propose a new terminology, based on symptoms and imaging together, to clarify the classification.

Why "cochlear Ménière's" matters on a tinnitus site

That phrase is the reason this article is here.

Vestibular presentation: the balance symptoms without the hearing ones. Cochlear presentation: the hearing symptoms — fluctuating hearing loss, aural pressure, tinnitus — without the vertigo attacks.

If you have fullness in one ear, hearing that comes and goes, and tinnitus that changes with it, and you have been told you do not have Ménière's because you have never had an attack of spinning, this is the framework in which that makes sense. The criteria for Ménière's disease require the vertigo. The 2016 review's argument is that the same underlying hydrops can be present without it.

That does not mean anyone with ear fullness has hydrops — Eustachian tube dysfunction and a patulous Eustachian tube are far commoner explanations for fullness, and neither involves the inner ear. What it means is that "you do not meet the criteria" is a statement about a checklist, not the end of the question, and that the fluctuation is the feature worth describing carefully to a clinician. Fluctuating is different from constant, and it is the word that changes the differential.

Secondary hydrops: when something caused it

A 2017 review in Otology & Neurotology deals with the other half — hydrops that follows an identifiable insult rather than arising on its own. It describes secondary endolymphatic hydrops as a pathological finding of the inner ear producing episodic vertigo and intermittent hearing loss, and lists the causes recent investigation has pointed to:

• Post-surgical effects of cochlear implantation and of endolymphatic sac ablation.
• Otosclerosis and the operations performed for it.
• Acoustic and mechanical trauma — the review names both, which puts noise exposure and head injury on the list.
• Medications. The site's ototoxic medications article covers the classes with documented inner-ear effects.
• Systemic inflammatory processes — which is where autoimmune inner ear disease sits.

The reason to separate primary from secondary is practical. A secondary hydrops has something behind it, and that something may be treatable, avoidable, or already known about. It also reframes a symptom that started after an operation or an acoustic incident: a mechanism that connects the two exists and has been described, rather than the timing being a coincidence you are inventing.

What to do with this

• If a report or a clinician says "hydrops", ask whether they mean an imaging finding, a working diagnosis, or a description of the symptom pattern. All three usages exist and they are not equivalent.
• If you have fluctuating hearing, fullness and tinnitus but no vertigo, say "fluctuating" explicitly. It is the word that moves this onto the differential, and a cochlear presentation is a recognised one.
• If your symptoms began after ear surgery, an acoustic incident, or a new medication, mention the sequence. Secondary hydrops is described in the literature and the timing is information, not noise.
• If you have been offered inner-ear MRI, it is a specialised protocol rather than a routine scan, and it is what made this finding visible in living patients for the first time in seventy-five years.
• If you have vertigo attacks alongside all of this, Ménière's disease is the page to read next, and vestibular migraine is the diagnosis most often confused with it.